Aug. 18 at 3:24 PM
$PDSB I hear frequent bankruptcy chatter here. There is no current threat of bankruptcy. Yes, they are low on cash. They will likely stay low on cash. They will sell additional stock only when they really need the funds. This is a prudent approach given the low stock price. They will limp through the phase 3. If the results look anything like the phase 2, it is on to FDA approval. Their data is awesome. You do not just get lucky and have a bunch of persons who are really sick live years longer.
They are staying lean when it comes to expenses.
They have very valuable assets. They would sell the company rather than go bankrupt. It is worth more than the current stock price.
Yes, the stock price is frustrating. There is a long history to that. This company has been under attack by shorts and those who hold all vaccine approaches to cancer do not work.
